[Commentary on] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 Journal Article

  


Authors: Wasserheit, C.; Mills, N. E.
Article Title: [Commentary on] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
Keywords: immunohistochemistry; drug therapy, combination; disease progression; neoplasm metastasis; chemotherapy, cancer; antibodies, monoclonal -- therapeutic use; breast neoplasms -- metabolism; female
Journal Title: Women's Oncology Review
Volume: 1
Issue: 2
ISSN: 1473-3404
Publisher: Taylor & Francis Group  
Date Published: 2001-06-01
Start Page: 175
End Page: 176
Language: English
ACCESSION: 2004131917
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:

http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=2004131917&site=ehost-live
Notes: Accession Number: 2004131917 -- Entry Date: 20040806 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al -- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 -- N ENGL J MED 2001 Mar 15; 344(11): 783-92 (research) -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20